RG
APRE icon

Redmile Group’s Aprea Therapeutics APRE Stock Holding History

Redmile Group’s Portfolio APRE Stock Details APRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-34,746
Closed -$3.55M – 73
2021
Q3 		$3.55M Hold
34,746
– – 0.06% 70
2021
Q2 		$3.39M Hold
34,746
– – 0.05% 82
2021
Q1 		$3.54M Sell
34,746
-28,690
-45% -$3.35M 0.05% 81
2020
Q4 		$6.24M Sell
63,436
-50,000
-44% -$23.8M 0.08% 76
2020
Q3 		$54.6M Hold
113,436
– – 1% 34
2020
Q2 		$88M Hold
113,436
– – 1.62% 18
2020
Q1 		$78.9M Hold
113,436
– – 2.21% 12
2019
Q4 		$104M Buy
+113,436
New +$62.5M 2.49% 14

Other funds holding APRE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PP
PDT Partners New York $1.69B AUM 74.01% 1-Year Est. Return